Jakob Spogis

Jakob Spogis

Auto-generated profile, based on publicly available information

Jakob Spogis

Department of Diagnostic and Interventional Radiology, University Hospital Tuebingen, 72076 Tuebingen, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2025 in Journal of Pediatric Surgery
Verified
Journal Article
Open access
TJTobias Jhala
Tobias Jhala
TLTobias Luithle
Tobias Luithle
CUCristian Urla
Cristian Urla
JSJakob Spogis
Jakob Spogis
JFJörg Fuchs
Jörg Fuchs
Megacalycosis is a rare non-obstructive congenital anomaly of the kidneys. The underlying pathogenesis has not yet been understood. Theories include the coexistence of distinct calyceal developmental stages, malformation of the calyceal structure, and transient, self-limiting obstruction. The management of this condition consists of close sonographic and functional follow-up. It is of the utmost importance to differentiate between an obstructive cause of hydronephrosis, although this can be challenging. Avoiding unnecessary surgical intervention is a crucial objective in this regard. The number of case series is limited, and the follow-up periods are often brief. The study included pediatric patients with megacalycosis who had been treated at the institution between 2009 and 2024. The extracted data comprised demographics, prior treatments, and follow-up data concerning sonographic and functional tests. The two-sample Student's t-test or the Mann-Whitney-U test were employed, depending on the normality of the distribution of the variables. The statistical analysis was conducted using Microsoft Excel 365. A total of 19 affected kidneys in 18 patients were identified. The median follow-up period was 5 years (range 1.2-13). All patients exhibited stable renal function at Tc-99m MAG3 scintigraphy. While a plateau phase was evident in the majority of patients following furosemide injection, delayed tracer clearance 40-60 min later was adequate. In cases where the diagnosis was uncertain or where prior surgery had been performed, retrograde pyelography was a valuable additional tool for ruling out obstruction. This is the largest series with the longest follow-up period of patients affected by megacalycosis to date. The diagnostic process can be challenging. The only appropriate management is non-operative, which preserves renal function. Retrograde pyelography can be a useful additional tool in cases where the diagnosis is uncertain.

23 March 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GHGretha Hecke
Gretha Hecke
BHBianca Haase
Bianca Haase
NCNikolaus Clodi
Nikolaus Clodi
KHKarolin Hauptvogel
Karolin Hauptvogel
DPDavid Plajer
David Plajer
SNSarah Nordmeyer
Sarah Nordmeyer
Objectives: During cardiac magnetic resonance imaging (cMRI) exams in patients with congenital heart disease (CHD), incidental liver abnormalities are increasingly found. However, no systematic data exist on the incidence of liver lesions in patients with different CHDs. In order to gain a first overview, we retrospectively analyzed cMRI examinations from the last 10 years at our institution. Methods: CMRI examinations including T2-weighted images covering parts of the liver were performed on 899 patients with CHD at our institution between 2014 and 2024. The cMRI examinations were analyzed by a medical student, a pediatrician, a radiologist, and a pediatric cardiologist. Liver lesions were defined as atypical liver parenchyma, showing T2 hyper- or hypointensity compared to the surrounding liver tissue. Results: Liver lesions were found in 9.5% (85/899) of all cMRI studies; of these, 89% ((76/85) of cases) were unknown at time of cMRI, 96% (82/85) were T2 hyperintense, and 38% (32/85) were larger than 1 cm. The patients with liver lesions were older (29 years vs. 22 years, p < 0.0001). There were no sex differences in the incidence of liver lesions or differences in right or left ventricular function (LVEF: 57% vs. 58%, p = 0.78; RVEF: 55% vs. 54%, p = 0.35). The patients with univentricular hearts, transposition of great arteries after atrial switch operation, and atrial septal defects showed the highest incidence (18%, 17%, and 21%, respectively). However, 9% of patients with left heart-sided valve disease also showed liver lesions. Conclusions: Incidental findings of liver lesions in cMRI examinations of patients with CHD are reasonably high with almost 10%. In the growing population of adults with CHD, liver monitoring might be helpful to assure overall patient health.

30 October 2025 in Investigative Radiology
Verified
Journal Article
Closed access
JSJakob Spogis
Jakob Spogis
MWMarcus Weitz
Marcus Weitz
PMPetros Martirosian
Petros Martirosian
TLTobias Luithle
Tobias Luithle
CUCristian Urla
Cristian Urla
JSJürgen F. Schäfer
Jürgen F. Schäfer
Background: Functional imaging of the kidney in pediatric patients is typically performed using contrast-enhanced MR urography (MRU) or nuclear scintigraphy, both of which require either gadolinium-based contrast agents or ionizing radiation. Furosemide, a loop diuretic routinely used in both modalities to stimulate urinary flow, acutely increases tubular fluid volume. These changes in renal water content can be detected by MRI-based quantitative T2 mapping, which may provide a contrast- and radiation-free alternative for evaluating kidney function. Objective: To assess renal T2 relaxation time changes following intravenous furosemide administration as a surrogate marker for differential renal function (DRF) in pediatric MRU. Materials and Methods: In this prospective single-center study (June 2024 to March 2025), pediatric patients undergoing clinically indicated MRU received additional dynamic T2 mapping during furosemide administration using a respiratory-triggered gradient-and-spin-echo (GraSE) sequence. Two readers independently assessed T2 relaxation time changes. DRF was derived from the slope of the T2 increase (SlopeDRF) as well as from pre-T2 to post-T2 differences, expressed as each kidney’s relative contribution to total function. These measures were compared with contrast-enhanced, Patlak-derived DRF (pDRF) using Pearson correlation and Bland-Altman analysis. Interreader agreement was assessed with the intraclass correlation coefficient (ICC). Results: Thirty-two patients (16 males; median age: 7 y, IQR: 0 to 11) were included. Renal parenchymal T2 relaxation times increased significantly after furosemide administration (pre: 118.4 ms, IQR: 110.8 to 124.4; post: 134.8 ms, IQR: 126.9 to 141.3; P < 0.001). SlopeDRF correlated strongly with pDRF (r = 0.81), and T2-difference DRF also demonstrated strong correlation with pDRF (r = 0.80). Interreader agreement for DRF was excellent (ICC = 0.94). Conclusion: Dynamic renal T2 mapping after intravenous furosemide administration shows strong correlation with Patlak-derived DRF from contrast-enhanced MRU and may provide a noninvasive, contrast- and radiation-free method for quantifying differential renal function in children.